COVID-19 Booster Vaccination in Persons With Multiple Sclerosis

Condition:   PWMS Who Have Completed Vaccination Against COVID-19 and Test Negative for COVID-19 Spike Protein Antibodies Using a Commercial Assay Interventions:   Biological: Homologous booster;   Biological: Heterologous booster Sponsors:   Griffin Hospital;   Yale-Griffin Prevention Research Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials